The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce ...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

Analysts have set 12-month price targets for Merit Medical Systems, revealing an average target of $114.12, a high estimate ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

The recent passing of Jiggly Caliente highlights the dangers of infection after leg amputation Read ahead to know about the ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global ...